Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,348 | 155 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $573.29 | 36 | $0 (2023) |
| GENZYME CORPORATION | $356.73 | 11 | $0 (2019) |
| PFIZER INC. | $292.96 | 16 | $0 (2020) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $237.28 | 10 | $0 (2019) |
| Galderma Laboratories, L.P. | $211.18 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $200.37 | 12 | $0 (2020) |
| Lilly USA, LLC | $198.01 | 11 | $0 (2020) |
| Allergan, Inc. | $179.00 | 5 | $0 (2022) |
| LEO Pharma Inc. | $163.25 | 11 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $124.91 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $179.73 | 14 | AbbVie Inc. ($147.50) |
| 2022 | $52.95 | 3 | Allergan, Inc. ($52.95) |
| 2021 | $19.60 | 1 | Smith+Nephew, Inc. ($19.60) |
| 2020 | $286.98 | 15 | AbbVie Inc. ($61.12) |
| 2019 | $1,130 | 50 | AbbVie, Inc. ($240.51) |
| 2018 | $1,083 | 56 | Ortho Dermatologics, a division of Bausch Health US, LLC ($169.58) |
| 2017 | $595.75 | 16 | GENZYME CORPORATION ($146.24) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $10.90 | General |
| 10/27/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $2.61 | General |
| 10/26/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/02/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $21.96 | General |
| 08/03/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/01/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/30/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $32.23 | General |
| Category: Musculoskeletal | ||||||
| 04/28/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/25/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $3.34 | General |
| 02/07/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: IMMUNOLOGY | ||||||
| 02/03/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $26.17 | General |
| 01/30/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $13.11 | General |
| 01/30/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $2.20 | General |
| 01/24/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $21.74 | General |
| 11/12/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/07/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $18.29 | General |
| 05/06/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/05/2021 | Smith+Nephew, Inc. | CORI (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Recon Robotics | ||||||
| 11/04/2020 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/28/2020 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Immunology | ||||||
| 09/08/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/25/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Immunology | ||||||
| 08/19/2020 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Immunology | ||||||
| 08/16/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: DERMATOLOGY | ||||||
| 08/10/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 176 | 307 | $39,673 | $10,567 |
| 2022 | 4 | 56 | 102 | $10,997 | $3,163 |
| 2021 | 12 | 1,059 | 1,961 | $411,462 | $87,609 |
| 2020 | 16 | 1,197 | 2,006 | $339,525 | $86,307 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $8,878 | $2,611 | 29.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 29 | 33 | $8,155 | $2,237 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 45 | $6,171 | $1,742 | 28.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 42 | 48 | $7,838 | $1,680 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 29 | $6,357 | $1,614 | 25.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 31 | 140 | $2,274 | $683.93 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 19 | $4,211 | $1,321 | 31.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 11 | 11 | $2,776 | $791.31 | 28.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 15 | 19 | $3,126 | $774.11 | 24.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 11 | 53 | $884.04 | $277.16 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 200 | 271 | $94,457 | $24,659 | 26.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 132 | 165 | $68,029 | $12,563 | 18.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 89 | 101 | $45,421 | $8,993 | 19.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 67 | 67 | $30,045 | $7,942 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 127 | 147 | $35,996 | $7,837 | 21.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 164 | 209 | $53,575 | $7,741 | 14.4% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 33 | 39 | $25,102 | $5,163 | 20.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 127 | 803 | $20,847 | $4,360 | 20.9% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 54 | 88 | $18,343 | $4,121 | 22.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 41 | 41 | $12,299 | $2,560 | 20.8% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 13 | 14 | $7,241 | $1,655 | 22.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 12 | 16 | $107.36 | $15.74 | 14.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 206 | 233 | $59,998 | $19,872 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 183 | 246 | $39,487 | $13,591 | 34.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 141 | 162 | $54,417 | $11,771 | 21.6% |
About Dr. Megan Brown, MD
Dr. Megan Brown, MD is a Dermatology healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1386087617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Megan Brown, MD has received a total of $3,348 in payments from pharmaceutical and medical device companies, with $179.73 received in 2023. These payments were reported across 155 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,348).
As a Medicare-enrolled provider, Brown has provided services to 2,488 Medicare beneficiaries, totaling 4,376 services with total Medicare billing of $187,646. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Tyler, TX
- Active Since 04/17/2013
- Last Updated 11/07/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1386087617
Products in Payments
- Humira (Biological) $364.67
- EUCRISA (Drug) $292.96
- DUPIXENT (Drug) $210.49
- TALTZ (Drug) $198.01
- ENSTILAR (Drug) $163.25
- COSENTYX (Biological) $141.86
- SILIQ (Drug) $129.10
- ATOPIC DERMATITIS - DISEASE (Drug) $124.99
- STELARA (Biological) $124.91
- BOTOX COSMETIC (Biological) $101.02
- SKYRIZI (Biological) $81.81
- Enbrel (Biological) $71.50
- EPIDUO FORTE (Drug) $68.77
- DUPIXENT DUPILUMAB INJECTION (Biological) $67.37
- Tremfya (Drug) $62.16
- BOTOX (Biological) $59.44
- Verdeso (Drug) $56.98
- Seysara (Drug) $51.17
- ABSORICA (isotretinoin) (Drug) $46.15
- XOLAIR (Biological) $40.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Tyler
Jennifer Holman, Md, MD
Dermatology — Payments: $705,235
Lindsey Hunter-Ellul, Md, MD
Dermatology — Payments: $11,358
Martha Mccollough, Md, MD
Dermatology — Payments: $10,842
Leslie Markle, Md, MD
Dermatology — Payments: $8,660
Alma Berlingeri Ramos, Md, MD
Dermatology — Payments: $4,757
Jeffrey Harbold, Do, DO
Dermatology — Payments: $4,013